Company Overview
Snapshot
Founded in April 2019 by Omer Kotlicki, Luma Biophotonics operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing a sensitive, affordable, compact, multi-omics diagnostic platform for personalized healthcare at home.
Business overview
Luma Biophotonics is a deep tech company specializing in home diagnostic devices within the Health Tech & Life Sciences sector. The company's core technology is based on pioneering and developing the world's first fully operational polymeric Photonic Integrated Circuits (PICs). These PICs offer optical properties comparable to silicon counterparts but at a significantly reduced cost, enabling sensitive, rapid, multi-omics diagnostic solutions for the home testing market. Luma Biophotonics serves the healthcare industry, targeting both patients and providers with its diagnostic devices.
Log in to access full profile ›Company Intelligence Q&A
- What is Luma Biophotonics' primary focus?
- Luma Biophotonics is focused on developing a sensitive, affordable, compact, multi-omics diagnostic platform for personalized healthcare at home.
- What technology underpins Luma Biophotonics' diagnostic platform?
- Luma Biophotonics' technology is based on Photonic Integrated Circuits (PICs), specifically pioneering the development of fully operational polymeric PICs.
- When was Luma Biophotonics founded?
- Luma Biophotonics was founded in April 2019.
- Who is a co-founder of Luma Biophotonics?
- Omer Kotlicki is a co-founder of Luma Biophotonics.
- What market does Luma Biophotonics target with its technology?
- Luma Biophotonics targets the home testing market with its low-cost, sensitive, rapid, multi-omics diagnostic solution.